Go to GE Healthcare Life Sciences

Hybridoma and myeloma platform media

Increase process yields in the manufacture of monoclonal antibodies (MAbs) from hybridoma and recombinant myeloma cell lines using our serum-free hybridoma and myeloma platform media.

  • HyClone™ ADCF-MAb Media

    HyClone ADCF-MAb media

    Catalog #: Multiple catalog numbers exist

    Increase process yields for the manufacture of monoclonal antibodies (MAbs) with a protein-free media containing no animal-derived components.

  • HyClone™ CCM1™ Media

    HyClone CCM1 media

    Catalog #: Multiple catalog numbers exist

    Support growth of a variety of hybridoma and myeloma cell lines with an early generation protein-containing serum-free medium.

  • HyClone™ CDM4MAb™ Media

    HyClone CDM4MAb media

    Catalog #: Multiple catalog numbers exist

    Increase process yields for the manufacture of monoclonal antibodies with this chemically-defined medium.

  • HyClone™ CDM4NSO™ Media

    HyClone CDM4NS0 media

    Catalog #: Multiple catalog numbers exist

    Increase process yields in the manufacturing of monoclonal antibodies (MAbs) using a variety of NS0 cell clones with media designed to require no cholesterol or GS supplementation.

  • HyClone™ PF-MAb™ Media

    HyClone PF-MAb media

    Catalog #: Multiple catalog numbers exist

    Reduce or minimize serum dependency in hybridoma and myeloma cell lines with this medium, a 100X concentrate designed for use with RPMI 1640 and other basal formulations.

  • HyClone™ SFM4MAb™ Media

    HyClone SFM4MAb media

    Catalog #: Multiple catalog numbers exist

    Increase process yields for manufacturing of human and humanized recombinant antibodies for therapeutic use with this serum-free medium.

  • HyClone™ SFM4MAb™-Utility Media

    HyClone SFM4MAb-utility media

    Catalog #: Multiple catalog numbers exist

    Support the growth of multiple hybridoma cell types and production of a variety of immunoglobulins with this versatile serum-free cell culture medium.